title: Mucinous cancers have fewer genomic alterations than more common classes of breast cancer.
abstract: Mucinous cancers of the breast are distinguished histologically by their abundant pools of mucin and low degree of nuclear pleomorphism. Relative to the more common breast cancers of no distinctive type (ductal carcinoma), mucinous cancers have a relatively favorable prognosis. In a study of chromosomal changes in mucinous cancers, we evaluated the extent of loss of heterozygosity (LOH) at chromosomal regions commonly deleted in usual infiltrating ductal carcinoma, including markers on chromosomal arms 1p, 1q, 3p, 6q, 8p, 9p, 11p, 11q, 13q, 16q, 17p, and 17q. Remarkably, we found an average frequency of LOH of only 1.9 of these 12 chromosomal arms in 18 cases of mucinous carcinoma, compared to an average frequency of LOH of 6.4 of these same chromosomal arms in cases of infiltrating ductal cancer. In three of the 18 cases of mucinous carcinoma studied, including one case with regional lymph node metastases, no LOH was seen at any of the 12 chromosomal regions studied. We considered the possibility of other chromosomal loci being more commonly affected in mucinous cancers and conducted comparative genomic hybridization on six of the cases. These studies demonstrated a low overall frequency of genomic copy number changes (mean of 3.1 changes per case) and failed to reveal any other chromosomal locus with frequent losses that had not been evaluated by microsatellite analysis. Together, these data indicate that mucinous cancers of the breast do not have the extensive genomic alterations that are typically found in more common variants of breast cancer. Thus, mucinous cancers most likely have less genetic instability than most other forms of breast cancer and the molecular pathogenesis of this form of breast cancer is likely to be substantially different than that of usual ductal breast cancer.
authors.affiliation: Department of Pathology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Fujii
authors.forename: Ramaswamy
authors.initials: R
authors.lastname: Anbazhagan
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Bornman
authors.forename: Elizabeth S
authors.initials: ES
authors.lastname: Garrett
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Perlman
authors.forename: Edward
authors.initials: E
authors.lastname: Gabrielson
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000235:genetics*; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000145:classification / Q000235:genetics*; D018270:Carcinoma, Ductal, Breast / Q000235:genetics; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000235:genetics; D002877:Chromosomes, Human / Q000235:genetics*; D005819:Genetic Markers; D006801:Humans; D019656:Loss of Heterozygosity / Q000235:genetics*; D018895:Microsatellite Repeats / Q000235:genetics; D009693:Nucleic Acid Hybridization / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D005819:Genetic Markers